2017 annual financial data
BioMarin Pharmaceutical 2017 Operating margin
Direct answer
Operating margin was -1.12%.
Operating income was -14,700,000 USD and net income was -117,042,000 USD.
Operating cash flow was -8,757,000 USD.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,313,646,000 USD
- Operating income
- -14,700,000 USD
- Net income
- -117,042,000 USD
- Operating cash flow
- -8,757,000 USD